Cardiovascular Systems Inc (NASDAQ:CSII) has coverage initiated with a Buy rating and $45.00 price target

Analyst Ratings For Cardiovascular Systems Inc (NASDAQ:CSII)

Story continues below

Today, Stifel Nicolaus initiated coverage on Cardiovascular Systems Inc (NASDAQ:CSII) with a Buy with a price target of $45.00.

There are 4 Hold Ratings, 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Cardiovascular Systems Inc (NASDAQ:CSII) is Buy with a consensus target price of $37.00 per share, a potential 2.71% downside.

Some recent analyst ratings include

  • 8/22/2018-Cardiovascular Systems Inc (NASDAQ:CSII) has coverage initiated with a Buy rating and $45.00 price target
  • 8/1/2018-Cardiovascular Systems Inc (NASDAQ:CSII) had its Buy rating reiterated by Lake Street Capital with a $50.00 price target
  • 6/27/2018-Cardiovascular Systems Inc (NASDAQ:CSII) gets upgraded to Buy by Bank of America
  • 5/3/2018-Cardiovascular Systems Inc (NASDAQ:CSII) had its Hold rating reiterated by Needham & Company LLC
  • 12/21/2017-Cardiovascular Systems Inc (NASDAQ:CSII) had its Market Perform rating reiterated by William Blair
  • 12/4/2017-Cardiovascular Systems Inc (NASDAQ:CSII) had its Hold rating reiterated by Raymond James

Recent Insider Trading Activity For Cardiovascular Systems Inc (NASDAQ:CSII)
Cardiovascular Systems Inc (NASDAQ:CSII) has insider ownership of 3.30% and institutional ownership of 86.76%.

  • On 8/17/2018 Alexander Rosenstein, General Counsel, sold 1,344 with an average share price of $37.56 per share and the total transaction amounting to $50,480.64.
  • On 8/17/2018 Jeffrey S Points, CFO, sold 971 with an average share price of $37.54 per share and the total transaction amounting to $36,451.34.
  • On 8/17/2018 Sandra Sedo, Insider, sold 862 with an average share price of $37.52 per share and the total transaction amounting to $32,342.24.
  • On 5/18/2018 Alexander Rosenstein, General Counsel, sold 190 with an average share price of $30.11 per share and the total transaction amounting to $5,720.90.
  • On 5/18/2018 Jeffrey S Points, CFO, sold 278 with an average share price of $30.09 per share and the total transaction amounting to $8,365.02.
  • On 8/31/2017 Edward M Brown, Director, sold 20,000 with an average share price of $29.16 per share and the total transaction amounting to $583,200.00.
  • On 8/30/2017 Edward M Brown, Director, sold 13,031 with an average share price of $29.09 per share and the total transaction amounting to $379,071.79.

About Cardiovascular Systems Inc (NASDAQ:CSII)
Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Recent Trading Activity for Cardiovascular Systems Inc (NASDAQ:CSII)
Shares of Cardiovascular Systems Inc closed the previous trading session at 38,03 +0,43 1,14 % with 37.59 shares trading hands.

An ad to help with our costs